23 Recruiting Studies Using Vinblastine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Vinblastine
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
Classical Hodgkin Lymphoma
View Study & Checklist ➔Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Ann Arbor Stage I Hodgkin Lymphoma
View Study & Checklist ➔Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
📍 Children's Hospital of Alabama ( Site 0023) — Birmingham, Alabama
Hodgkin Lymphoma
View Study & Checklist ➔A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent Low Grade Astrocytoma
View Study & Checklist ➔A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
📍 Indiana University — Bloomington, Indiana
Urothelial Carcinoma
View Study & Checklist ➔Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
📍 Children's Hospital Los Angeles — Los Angeles, California
Low Grade Glioma
View Study & Checklist ➔A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
📍 Children's Hospital Colorado — Aurora, Colorado
Hodgkin Disease
View Study & Checklist ➔A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
📍 Karmanos Cancer Institute — Detroit, Michigan
Hodgkin Lymphoma
View Study & Checklist ➔LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
📍 Children's of Alabama — Birmingham, Alabama
Langerhans Cell Histiocytosis
View Study & Checklist ➔Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ann Arbor Stage III Hodgkin Lymphoma
View Study & Checklist ➔Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma
📍 Stanford Cancer Center — Stanford, California
Classic Hodgkin Lymphoma
View Study & Checklist ➔Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Ann Arbor Stage I Hodgkin Lymphoma
View Study & Checklist ➔Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Hodgkin Lymphoma
View Study & Checklist ➔Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
📍 New York Medical College — Valhalla, New York
Anaplastic Large Cell Lymphoma, ALK-Positive
View Study & Checklist ➔A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
📍 Children's Hospital of Alabama — Birmingham, Alabama
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
View Study & Checklist ➔A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
📍 University of Miami — Miami, Florida
Hodgkin Lymphoma
View Study & Checklist ➔Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas
📍 The Hospital for Sick Children — Toronto, Ontario
Low-grade Glioma
View Study & Checklist ➔Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
📍 Research Site — Chermside,
Urinary Bladder Neoplasms
View Study & Checklist ➔Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
📍 Stanford University - (Stanford Cancer Institute) — Stanford, California
Hodgkin Lymphoma
View Study & Checklist ➔Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
📍 Stanford Children's Hospital, Lucile Packard Children's Hospital — Palo Alto, California
Langerhans Cell Histiocytosis
View Study & Checklist ➔Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
📍 Kingman Regional Medical Center — Kingman, Arizona
Renal Pelvis and Ureter Urothelial Carcinoma
View Study & Checklist ➔Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma
📍 City of Hope — Irvine, California
Advanced Hodgkin Lymphoma
View Study & Checklist ➔Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
📍 UT MD Anderson — Houston, Texas
Hodgkin Lymphoma
View Study & Checklist ➔